Caberol tablets should be taken orally, preferably with food, to minimize gastrointestinal side effects. It is usually taken twice a week on specific days (e.g., Monday and Thursday).

Cabergoline is a synthetic ergot derivative and a potent, long-acting dopamine D2 receptor agonist. It selectively binds to D2 receptors on lactotroph cells in the anterior pituitary gland, thereby inhibiting the synthesis and secretion of prolactin.

• •Hypersensitivity to cabergoline or any other ergot derivatives
• •Uncontrolled hypertension
• •History of pulmonary, pericardial, or retroperitoneal fibrotic disorders
• •Valvular heart disease (confirmed by echocardiography prior to treatment)
• •Pregnancy-induced hypertension (preeclampsia, eclampsia)
• •Postpartum hypertension

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Symptoms of overdose may include nasal congestion, syncope, hallucinations, or psychosis. Treatment is symptomatic and supportive. Gastric lavage and dopamine antagonist administration may be considered.

Pregnancy Category B. Use only if clearly needed and the potential benefits outweigh the potential risks to the fetus. It is contraindicated in cases of pregnancy-induced hypertension. Cabergoline inhibits lactation and should not be used in mothers who choose to breastfeed unless clinically indicated to suppress lactation.